الإحصائيات الأساسية
| CIK | 748270 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Medical Action Industries Inc
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| February 5, 2015 |
SC 13G/A 1 rrd315.htm SCHEDULE 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* MEDICAL ACTION IND INC (Name of Issuer) Common Stock (Title of Class of Securities) 58449L100 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desig |
|
| October 2, 2014 |
MDCI / Medical Action Industries Inc / GAMCO INVESTORS, INC. ET AL Activist Investment SC 13D/A 1 mdci02.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) Medical Action Industries Inc. (Name of Issuer) Common Stock ($0.001 par value) (Title of Class of Securities) 58449L100 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address |
|
| September 30, 2014 |
Termination of a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2014 (September 29, 2014) Medical Action Industries Inc. |
|
| September 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A AMENDMENT NO. 2 (Mark one) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2014 Or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-1 |
|
| September 23, 2014 |
8-K 1 f8k092314.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 23, 2014 (September 19, 2014) Medical Action Industries Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or other jurisdict |
|
| September 15, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 15, 2014 Medical Action Industries Inc. |
|
| September 15, 2014 |
MDCI / Medical Action Industries Inc CORRESP - - CORRESP 1 filename1.htm 500 Expressway Drive South, Brentwood, NY 11717 Phone: 631.231.4600 Fax: 631.404.3899 www.medical-action.com September 15, 2014 Martin James Senior Assistant Chief Accountant Division of Corporate Finance Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Medical Action Industries Inc. Form 10-K for the Fiscal Year Ended March 31, 2014 Filed June |
|
| September 3, 2014 |
MDCI / Medical Action Industries Inc / GAMCO INVESTORS, INC. ET AL Activist Investment SC 13D/A 1 mdci01.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Medical Action Industries Inc. (Name of Issuer) Common Stock ($0.001 par value) (Title of Class of Securities) 58449L100 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Num |
|
| August 25, 2014 |
MDCI / Medical Action Industries Inc DEFM14A - - DEFINITIVE PROXY STATEMENT DEFM14A 1 defm14a082514.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: o Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as |
|
| August 11, 2014 |
Medical Action Industries Reports First Quarter Results for the Three Months Ended June 30, 2014 EXHIBIT 99.1 Medical Action Industries Reports First Quarter Results for the Three Months Ended June 30, 2014 BRENTWOOD, N.Y., Aug. 11, 2014 (GLOBE NEWSWIRE) - Medical Action Industries Inc. (the "Company") (Nasdaq:MDCI), a leading supplier of medical and surgical disposable products, today reported financial results for the first quarter ended June 30, 2014. On June 2, 2014, the Company completed |
|
| August 11, 2014 |
10-Q 1 f10q080814.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2014 COMMISSION FILE NUMBER 000-13251 MEDICAL ACTION INDUSTRIES INC. (Exact name of registrant as specified in its charter) DELAWARE 11-2421849 (State or oth |
|
| August 11, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 11, 2014 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or other jurisdiction of incorporation) (Comm |
|
| August 8, 2014 |
Submission of Matters to a Vote of Security Holders 8-K 1 f8k080814.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2014 (August 7, 2014) Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State o |
|
| July 17, 2014 |
MDCI / Medical Action Industries Inc PREM14A - - PRELIMINARY PROXY STATEMENT PREM14A 1 prem14a071614.htm PRELIMINARY PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ý Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as |
|
| July 3, 2014 |
MDCI / Medical Action Industries Inc / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Medical Action Industries Inc. (Name of Issuer) Common Stock ($0.001 par value) (Title of Class of Securities) 58449L100 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authoriz |
|
| June 25, 2014 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report: June 25, 2014 Medical Action Industries Inc. |
|
| June 25, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events 8-K 1 f8k062514.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 25, 2014 (June 24, 2014) Medical Action Industries Inc. (Exact Name of Registrant as Specified in Charter) Delaware 000-13251 11-2421849 (State or othe |
|
| June 25, 2014 |
Exhibit 2.2 EXECUTION VERSION VOTING AGREEMENT BY AND BETWEEN OWENS & MINOR, INC. AND PAUL D. MERINGOLO DATED AS OF JUNE 24, 2014 VOTING AGREEMENT VOTING AGREEMENT, dated as of June 24, 2014 (this “Agreement”), by and among Owens & Minor, Inc., a Virginia corporation (“Parent”), and Paul D. Meringolo (the “Stockholder”). W I T N E S S E T H: WHEREAS, concurrently with the execution of this Agreeme |
|
| June 25, 2014 |
Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among OWENS & MINOR, INC., MONGOOSE MERGER SUB INC. and MEDICAL ACTION INDUSTRIES INC. June 24, 2014 TABLE OF CONTENTS Page ARTICLE I THE MERGER Section 1.1 The Merger; Effective Time of the Merger 1 Section 1.2 Closing 1 Section 1.3 Effect of the Merger 2 Section 1.4 Certificate of Incorporation and Bylaws 2 Section 1.5 Directors a |
|
| June 25, 2014 |
EXHIBIT 99.1 Owens & Minor to Acquire Medical Action Industries, a Leading Provider of Procedure-Based Kits and Trays Acquisition of Medical Action aligns with Owens & Minor's strategy of Connecting the World of Medical Products to the Point of CareTM by expanding reach to the patient Medical Action's kitting capabilities complement Owens & Minor's existing procedure-based delivery service Expecte |
|
| June 25, 2014 |
EX-99.1 2 exh991.htm EXHIBIT 99.1 Exhibit 99.1 MEMORANDUM TO: All Medical Action Teammates FROM: Paul D. Meringolo, Chief Executive Officer DATE: June 25, 2014 RE: Owens & Minor, Inc. Acquires Medical Action Industries Inc. I am pleased to announce that Medical Action Industries Inc. (“Medical Action”) and Owens & Minor, Inc. (“Owens & Minor”) have signed a definitive agreement under which Owens & |
|
| June 25, 2014 |
EXHIBIT 99.1 Owens & Minor to Acquire Medical Action Industries, a Leading Provider of Procedure-Based Kits and Trays Acquisition of Medical Action aligns with Owens & Minor's strategy of Connecting the World of Medical Products to the Point of CareTM by expanding reach to the patient Medical Action's kitting capabilities complement Owens & Minor's existing procedure-based delivery service Expecte |
|
| June 25, 2014 |
Exhibit 2.2 EXECUTION VERSION VOTING AGREEMENT BY AND BETWEEN OWENS & MINOR, INC. AND PAUL D. MERINGOLO DATED AS OF JUNE 24, 2014 VOTING AGREEMENT VOTING AGREEMENT, dated as of June 24, 2014 (this “Agreement”), by and among Owens & Minor, Inc., a Virginia corporation (“Parent”), and Paul D. Meringolo (the “Stockholder”). W I T N E S S E T H: WHEREAS, concurrently with the execution of this Agreeme |
|
| June 25, 2014 |
EX-2.1 2 exh21.htm EXHIBIT 2.1 Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among OWENS & MINOR, INC., MONGOOSE MERGER SUB INC. and MEDICAL ACTION INDUSTRIES INC. June 24, 2014 TABLE OF CONTENTS Page ARTICLE I THE MERGER Section 1.1 The Merger; Effective Time of the Merger 1 Section 1.2 Closing 1 Section 1.3 Effect of the Merger 2 Section 1.4 Certificate of Incorporation and B |
|
| June 25, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 25, 2014 (June 24, 2014) Medical Action Industries Inc. |
|
| June 25, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report: June 25, 2014 Medical Action Industries Inc. |
|
| June 25, 2014 |
EX-99.1 2 exh991.htm EXHIBIT 99.1 Exhibit 99.1 MEMORANDUM TO: All Medical Action Teammates FROM: Paul D. Meringolo, Chief Executive Officer DATE: June 25, 2014 RE: Owens & Minor, Inc. Acquires Medical Action Industries Inc. I am pleased to announce that Medical Action Industries Inc. (“Medical Action”) and Owens & Minor, Inc. (“Owens & Minor”) have signed a definitive agreement under which Owens & |
|
| June 16, 2014 |
- DEFINITIVE ADDITIONAL MATERIALS DEFA14A 1 defa14a061614.htm DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for U |
|
| June 16, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| June 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2014 (June 2, 2014) Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or other jurisdiction (Commissi |
|
| June 11, 2014 |
EXHIBIT 99.1 Medical Action Industries Reports Fourth Quarter and Annual Results for the Fiscal Year Ended March 31, 2014 BRENTWOOD, N.Y., June 11, 2014 (GLOBE NEWSWIRE) - Medical Action Industries Inc. (the "Company") (Nasdaq:MDCI), a leading supplier of medical and surgical disposable products, today reported financial results for the fourth quarter and twelve months ended March 31, 2014 (such t |
|
| June 11, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 document.htm FORM 8-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 11, 2014 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or |
|
| June 3, 2014 |
Medical Action Industries Inc. Exhibit 99.2 MEDICAL ACTION INDUSTRIES INC. UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Introduction On June 2, 2014 (the “Closing Date”), Medical Action Industries Inc. (the “Company”), completed a purchase agreement (the “Agreement”) entered into with Medira, Inc., a Delaware corporation and subsidiary of Inteplast Group, Ltd., for approximately $78.6 million, subject to cust |
|
| June 3, 2014 |
Medical Action Industries Announces Completion of the Patient Care Transaction Exhibit 99.1 Medical Action Industries Announces Completion of the Patient Care Transaction BRENTWOOD, N.Y., June 2, 2014 (GLOBE NEWSWIRE) - Medical Action Industries Inc. (Nasdaq:MDCI) (the "Company" or "Medical Action"), announced today that it has completed its previously announced sale of its Medegen Medical Products, LLC subsidiary and certain other assets of its Patient Care business unit to |
|
| June 3, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 3, 2014 (June 2, 2014) Medical Action Industries Inc. |
|
| June 3, 2014 |
FIRST AMENDMENT TO CREDIT AGREEMENT AND GUARANTY AND SECURITY AGREEMENT EX-10.1 2 exh101.htm EXHIBIT 10.1 Exhibit 10.1 FIRST AMENDMENT TO CREDIT AGREEMENT AND GUARANTY AND SECURITY AGREEMENT This First Amendment to Credit Agreement and Guaranty and Security Agreement, dated as of June 2, 2014 (this “Agreement”) is entered into by and among Medical Action Industries, a Delaware corporation (the “Borrower”), the Guarantors listed on the signature pages hereof (the “Guar |
|
| May 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or other jurisdiction (Commission (IRS Employer of incorporation or organization) File Number) Identification No.) 500 Expressway Drive South Brentwood, New York 11717 |
|
| May 23, 2014 |
8-K 1 f8k052314.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2014 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or other jurisdict |
|
| March 13, 2014 |
EXHIBIT 99.1 Medical Action Industries to Sell Medegen and Certain Other Assets of Its Patient Care Business Unit to Inteplast Group BRENTWOOD, N.Y., March 13, 2014 (GLOBE NEWSWIRE) - Medical Action Industries Inc. (Nasdaq:MDCI) (the "Company" or "Medical Action"), announced today that it has signed a definitive agreement to sell its Medegen Medical Products, LLC subsidiary and certain other asset |
|
| March 13, 2014 |
8-K 1 f8k031314.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 13, 2014 (March 12, 2014) Medical Action Industries Inc. (Exact Name of Registrant as Specified in Charter) Delaware (State or other jurisdiction of i |
|
| March 13, 2014 |
Exhibit 2.1 PURCHASE AGREEMENT by and among MEDICAL ACTION INDUSTRIES INC. MEDIRA INC. and, solely for purposes of Sections 5.1(b) and 11.20, INTEPLAST GROUP, LTD. dated as of March 12, 2014 TABLE OF CONTENTS ARTICLE I DEFINITIONS Section 1.1. Definitions 1 Section 1.2. Headings; References; Interpretation 18 ARTICLE II PURCHASE AND SALE Section 2.1. Purchase and Sale of Units and Assets 19 Sectio |
|
| February 12, 2014 |
MDCI / Medical Action Industries Inc / Boston Partners Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Medical Action Industries Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58449L100 (CUSIP Number) December 31, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi |
|
| February 10, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* MEDICAL ACTION IND INC (Name of Issuer) Common Stock (Title of Class of Securities) 58449L100 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this S |
|
| February 5, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 document.htm FORM 8-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 5, 2014 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State |
|
| February 5, 2014 |
Medical Action Industries Reports Third Quarter Fiscal Year 2014 Results EXHIBIT 99.1 Medical Action Industries Reports Third Quarter Fiscal Year 2014 Results BRENTWOOD, N.Y., Feb. 5, 2014 (GLOBE NEWSWIRE) - Medical Action Industries Inc. (the "Company") (Nasdaq:MDCI), a leading supplier of medical and surgical disposable products, today reported financial results for the third quarter ended December 31, 2013, including net sales of $110.0 million and gross profit of $ |
|
| November 14, 2013 |
EX-99.1 2 exh991.htm EXHIBIT 99.1 EXHIBIT 99.1 |
|
| November 14, 2013 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 f8k111413.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2013 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or other jurisd |
|
| October 31, 2013 |
Medical Action Industries Reports Second Quarter Fiscal Year 2014 Results EXHIBIT 99.1 Medical Action Industries Reports Second Quarter Fiscal Year 2014 Results BRENTWOOD, N.Y., Oct. 31, 2013 (GLOBE NEWSWIRE) - Medical Action Industries Inc. (the "Company") (Nasdaq:MDCI), a leading supplier of medical and surgical disposable products, today reported financial results for the second quarter ended September 30, 2013, including net sales of $108.3 million and gross profit |
|
| October 31, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 31, 2013 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or other jurisdiction of incorporation) (Com |
|
| August 9, 2013 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2013 Medical Action Industries Inc. |
|
| August 1, 2013 |
Medical Action Industries Reports First Quarter Fiscal Year 2014 Results EXHIBIT 99.1 Medical Action Industries Reports First Quarter Fiscal Year 2014 Results BRENTWOOD, N.Y., Aug. 1, 2013 (GLOBE NEWSWIRE) - Medical Action Industries Inc. (the "Company") (Nasdaq:MDCI), a leading supplier of medical and surgical disposable products, today reported financial results for the first quarter ended June 30, 2013, including net sales of $107.2 million and gross profit of $17.7 |
|
| August 1, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 1, 2013 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or other jurisdiction of incorporation) (Commi |
|
| July 17, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 12, 2013 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or other jurisdiction (Commission (IRS Employe |
|
| July 17, 2013 |
Exhibit 10.1 June 28, 2013 John Sheffield [] [] Dear John: Below are the understandings that have been reached as a result of discussions regarding the separation of your employment from Medical Action Industries (“Medical Action” or “the Company”). Please read the following items and if, after reviewing, you agree that they conform to our discussions, you should indicate as much by countersigning |
|
| July 2, 2013 |
8-K 1 f8k070213.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2013 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or other jurisdic |
|
| July 2, 2013 |
/s/ Brian Baker July 1, 2013 Brian Baker Date EX-10.1 2 exh101.htm EXHIBIT 10.1 EXHIBIT 10.1 500 Expressway Drive South Brentwood, NY 11717 Phone: 631.231.4600 Fax: 631.404.3899 www.medical-action.com July 1, 2013 Mr. Brian Baker [] [] Dear Brian: On behalf of Medical Action Industries Inc. (the “Company”), it is with great pleasure that we offer you the opportunity for continued growth and success. As of July 1, 2013, you are promoted to the |
|
| June 19, 2013 |
- DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| June 19, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
| June 11, 2013 |
EX-99 2 newsrelease.htm PRESS RELEASE EXHIBIT 99.1 Medical Action Industries Reports Fourth Quarter and Annual Results for the Fiscal Year Ended March 31, 2013 BRENTWOOD, N.Y., June 11, 2013 (GLOBE NEWSWIRE) - Medical Action Industries Inc. (the "Company") (Nasdaq:MDCI), a leading supplier of medical and surgical disposable products, today reported financial results for the fourth quarter and the |
|
| June 11, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 document.htm FORM 8-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 11, 2013 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or |
|
| May 28, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2013 Medical Action Industries Inc. |
|
| May 23, 2013 |
8-K 1 f8k052313.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2013 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or other jurisdictio |
|
| May 22, 2013 |
EXHIBIT 10.1 EXECUTION VERSION CREDIT AGREEMENT by and among WELLS FARGO BANK, NATIONAL ASSOCIATION, as Administrative Agent, THE LENDERS THAT ARE PARTIES HERETO as the Lenders, and MEDICAL ACTION INDUSTRIES INC., as Borrower Dated as of May 17, 2013 TABLE OF CONTENTS Page 1. DEFINITIONS AND CONSTRUCTION. 1 1.1 Definitions 1 1.2 Accounting Terms 1 1.3 Code 1 1.4 Construction 1 1.5 Time References |
|
| May 22, 2013 |
8-K 1 f8k052213.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2013 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or other jurisdictio |
|
| February 11, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 document.htm FORM 8-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 11, 2013 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State |
|
| February 11, 2013 |
Medical Action Industries Reports Third Quarter Fiscal 2013 Results EXHIBIT 99.1 Medical Action Industries Reports Third Quarter Fiscal 2013 Results BRENTWOOD, N.Y., Feb. 11, 2013 (GLOBE NEWSWIRE) - Medical Action Industries Inc. (Nasdaq:MDCI), a leading supplier of medical and surgical disposable products, today reported financial results for the third quarter ended December 31, 2012, including quarterly net sales of $109.4 million and gross profit of $19.1 milli |
|
| February 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Medical Action Industries Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58449L100 (CUSIP Number) December 31, 2012 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi |
|
| January 16, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 11, 2013 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or other jurisdiction of incorporation) (Com |
|
| January 16, 2013 |
Medical Action Industries Announces Chief Operating Officer EXHIBIT 99.1 Medical Action Industries Announces Chief Operating Officer BRENTWOOD, N.Y., Jan. 14, 2013 (GLOBE NEWSWIRE) - Paul D. Meringolo, a member of the Board of Directors (our "Board") of Medical Action Industries Inc. (the "Company") (Nasdaq:MDCI) and its President and Chief Executive Officer, announced that the Company has begun the process of searching for a Chief Operating Officer. No de |
|
| November 29, 2012 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 f8k112912.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 27, 2012 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or other jurisd |
|
| November 29, 2012 | ||
| November 16, 2012 |
Grant Thornton LLP 445 Broad Hollow Road, Suite 300 Melville, NY 11747-3601 EXHIBIT 16.1 Grant Thornton LLP 445 Broad Hollow Road, Suite 300 Melville, NY 11747-3601 November 14, 2012 U. S. Securities and Exchange Commission Office of the Chief Accountant 100 F Street, NE Washington, DC 20549 Re: Medical Action Industries Inc. File No. 000-13251 Dear Sir or Madam: We have read Item 4.01 of Form 8-K of Medical Action Industries Inc. dated November 16, 2012, and agree with t |
|
| November 16, 2012 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant 8-K 1 f8k111612.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2012 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or other jurisd |
|
| November 2, 2012 |
Medical Action Industries Reports Second Quarter 2013 Results EXHIBIT 99.1 Medical Action Industries Reports Second Quarter 2013 Results BRENTWOOD, N.Y., Oct. 31, 2012 (GLOBE NEWSWIRE) - Medical Action Industries Inc. (Nasdaq:MDCI), a leading supplier of medical and surgical disposable products, today reported results for the fiscal 2013 second quarter ended September 30, 2012. Chief Executive Officer and President, Paul D. Meringolo said, "We continue to fo |
|
| November 2, 2012 |
8-K 1 f8k110212.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2012 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State or other jurisdi |
|
| November 2, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 document.htm FORM 8-K FILING DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 31, 2012 Medical Action Industries Inc. (Exact name of registrant as specified in its charter) Delaware 000-13251 11-2421849 (State |
|
| September 21, 2012 |
EXHIBIT 99.1 |
|
| September 21, 2012 |
Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 20, 2012 Medical Action Industries Inc. |
|
| August 9, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2012 Medical Action Industries Inc. |
|
| August 1, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 d388492d8k.htm FORM 8-K Table of Contents SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8 – K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report: August 1, 2012 (Date of earliest event reported) MEDICAL ACTION INDUSTRIES INC. (Exact name of registrant as specified in its charter) (Former name or former address, if changed sin |
|
| August 1, 2012 |
MEDICAL ACTION INDUSTRIES REPORTS FIRST QUARTER 2013 RESULTS Press Release Exhibit 99.1 500 Expressway Drive South, Brentwood, NY 11717 Phone: 631.231.4600 www.medical-action.com CONTACT: John Sheffield – Chief Financial Officer MEDICAL ACTION INDUSTRIES INC. (631) 231-4600 FOR IMMEDIATE RELEASE MEDICAL ACTION INDUSTRIES REPORTS FIRST QUARTER 2013 RESULTS BRENTWOOD, NY, August 1, 2012 – Medical Action Industries Inc. (the “Company” or “Medical Action”) (NAS |
|
| July 10, 2012 |
SC 13G/A 1 mdcia171012.htm ROBECO INVESTMENT MANAGEMENT INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Medical Action Industries Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58449L100 (CUSIP Number) June 30, 2012 (Date of Event which Requires Filing of this Statement) Check |
|
| June 22, 2012 |
- DEFINITIVE ADDITIONAL MATERIALS DEFA14A 1 d371310ddefa14a.htm DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of Commi |
|
| June 22, 2012 |
Definitive Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| June 14, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K Form 8-K Table of Contents SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8 – K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report: June 14, 2012 (Date of earliest event reported) MEDICAL ACTION INDUSTRIES INC. (Exact name of registrant as specified in its charter) Delaware 0-13251 11-2421849 (State or other jurisdiction of incorpor |
|
| June 14, 2012 |
MEDICAL ACTION INDUSTRIES REPORTS FOURTH QUARTER AND FISCAL 2012 RESULTS Press Release, dated June 14, 2012 Exhibit 99.1 500 Expressway Drive South, Brentwood, NY 11717 Phone: 631.231.4600 www.medical-action.com CONTACT: John Sheffield – Chief Financial Officer MEDICAL ACTION INDUSTRIES INC. (631) 231-4600 FOR IMMEDIATE RELEASE MEDICAL ACTION INDUSTRIES REPORTS FOURTH QUARTER AND FISCAL 2012 RESULTS BRENTWOOD, NY, June 14, 2012 – Medical Action Industries Inc. (the “Co |
|
| June 13, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8–K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2012 MEDICAL ACTION INDUSTRIES INC. (Exact name of registrant as specified in its charter) Delaware 0-13251 11-2421849 (State or other jurisdiction of incorporation) (Commissi |
|
| June 13, 2012 |
SECOND AMENDED AND RESTATED CREDIT AGREEMENT Exhibit 10.1 EXECUTION COPY SECOND AMENDED AND RESTATED CREDIT AGREEMENT Dated as of June 7, 2012 by and among MEDICAL ACTION INDUSTRIES INC. THE LENDERS PARTY HERETO JPMORGAN CHASE BANK, N.A. as Administrative Agent CITIBANK, N.A. as Syndication Agent and HSBC BANK USA, N.A., SOVEREIGN BANK, N.A. and WELLS FARGO BANK, N.A. as Co-Documentation Agents J. |
|
| May 31, 2012 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 d361767d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8–K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2012 MEDICAL ACTION INDUSTRIES INC. (Exact name of registrant as specified in its charter) Delaware 0-13251 11-2421849 (State or other jurisdicti |
|
| May 31, 2012 |
Waiver No. 2 to Amended and Restated Credit Agreement Exhibit 10.1 WAIVER NO. 2 Dated as of May 31, 2012 to AMENDED AND RESTATED CREDIT AGREEMENT Dated as of August 27, 2010 THIS WAIVER NO. 2 (this “Waiver”) is made as of May 31, 2012 (the “Effective Date”) by and among Medical Action Industries Inc., a Delaware corporation (the “Company”), the financial institutions listed on the signature pages |
|
| May 25, 2012 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8–K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2012 MEDICAL ACTION INDUSTRIES INC. (Exact name of registrant as specified in its charter) Delaware 0-13251 11-2421849 (State or other jurisdiction of incorporation) |
|
| April 24, 2012 |
8-K 1 d339765d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8–K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2012 MEDICAL ACTION INDUSTRIES INC. (Exact name of registrant as specified in its charter) Delaware 0-13251 11-2421849 (State or other jurisdic |
|
| April 24, 2012 |
MEDICAL ACTION INDUSTRIES ANNOUNCES PLAN TO REALIGN INTO STRATEGIC BUSINESS UNITS Press release Exhibit 99.2 500 Expressway Drive South, Brentwood, NY 11717 Phone: 631.231.4600 www.medical-action.com CONTACT: John Sheffield – Chief Financial Officer MEDICAL ACTION INDUSTRIES INC. (631) 231-4600 FOR IMMEDIATE RELEASE MEDICAL ACTION INDUSTRIES ANNOUNCES PLAN TO REALIGN INTO STRATEGIC BUSINESS UNITS BRENTWOOD, N.Y., April 19, 2012 – Medical Action Industries Inc. (NASDAQ: MDCI), a |
|
| April 24, 2012 |
Medical Action Announces Appointment of John Sheffield as Chief Financial Officer Press release Exhibit 99.1 500 Expressway Drive South, Brentwood, NY 11717 Phone: 631.231.4600 www.medical-action.com CONTACT: John Sheffield – Chief Financial Officer MEDICAL ACTION INDUSTRIES INC. (631) 231-4600 FOR IMMEDIATE RELEASE Medical Action Announces Appointment of John Sheffield as Chief Financial Officer BRENTWOOD, NY, March 15, 2012 – Medical Action Industries Inc. (NASDAQ/MDCI), a le |
|
| March 30, 2012 |
Waiver No. 1 Exhibit 10.1 WAIVER NO. 1 Dated as of March 30, 2012 to AMENDED AND RESTATED CREDIT AGREEMENT Dated as of August 27, 2010 THIS WAIVER NO. 1 (this “Waiver”) is made as of March 30, 2012 (the “Effective Date”) by and among Medical Action Industries Inc., a Delaware corporation (the “Company”), the financial institutions listed on the signature pages hereof as Lenders and JPMorgan Chase |
|
| March 30, 2012 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 d328342d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8–K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2012 MEDICAL ACTION INDUSTRIES INC. (Exact name of registrant as specified in its charter) Delaware 0-13251 11-2421849 (State or other jurisdic |
|
| March 14, 2012 |
Form 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8 – K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report: March 14, 2012 (Date of earliest event reported) MEDICAL ACTION INDUSTRIES INC. (Exact name of registrant as specified in its charter) (Former name or former address, if changed since last report) Delaware 0-13251 11-242 |
|
| February 14, 2012 |
Identification and Classification of the Subsidiary Exhibit I to Schedule 13G Ameriprise Financial, Inc., a Delaware Corporation, is a parent holding company. The classification and identity of the relevant subsidiaries is as follows: Investment Adviser – Columbia Management Investment Advisers, LLC is an investment adviser registered under section 203 of the Investment Advisers Act of 1940. |
|
| February 14, 2012 |
to Schedule 13G Joint Filing Agreement Joint Filing Agreement Exhibit II to Schedule 13G Joint Filing Agreement The undersigned persons agree and consent to the joint filing on their behalf of this Schedule 13G dated February 13, 2012 in connection with their beneficial ownership of Medical Action Industries, Inc. |
|
| February 14, 2012 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Amendment #1 Under the Securities and Exchange Act of 1934 Medical Action Industries, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58449L100 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul |
|
| February 6, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Medical Action Industries Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 58449L100 (CUSIP Number) December 31, 2011 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whic |
|
| February 2, 2012 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 d295166d8k.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report: February 1, 2012 (Date of earliest event reported) MEDICAL ACTION INDUSTRIES INC. (Exact name of registrant as specified in its charter) (Former name or former address, if changed since last report) De |
|
| February 2, 2012 |
MEDICAL ACTION INDUSTRIES REPORTS THIRD QUARTER 2012 RESULTS Press Release 500 Expressway Drive South, Brentwood, NY 11717 Phone: 631.231.4600 www.medical-action.com EXHIBIT 99.1 CONTACT: Charles L. Kelly – Chief Financial Officer MEDICAL ACTION INDUSTRIES INC. (631) 231-4600 FOR IMMEDIATE RELEASE MEDICAL ACTION INDUSTRIES REPORTS THIRD QUARTER 2012 RESULTS BRENTWOOD, NY, February 1, 2012 – Medical Action Industries Inc. (NASDAQ/MDCI), a leading supplier of |
